BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 23136990)

  • 1. Enhanced fabrication of size-controllable chitosan-genipin nanoparticles using orifice-induced hydrodynamic cavitation: Process optimization and performance evaluation.
    Zhang K; Zheng J; Xu Y; Liao Z; Huang Y; Lu L
    Ultrason Sonochem; 2024 Jun; 106():106899. PubMed ID: 38733852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Fabrications of Chitosan Nanoparticles for Effective Drug Delivery Using Flow Chemistry Reactors.
    Huanbutta K; Sriamornsak P; Suwanpitak K; Klinchuen N; Deebugkum T; Teppitak V; Sangnim T
    Int J Nanomedicine; 2023; 18():7889-7900. PubMed ID: 38146468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Assembled chitosan/phospholipid nanoparticles: from fundamentals to preparation for advanced drug delivery.
    Ma Q; Gao Y; Sun W; Cao J; Liang Y; Han S; Wang X; Sun Y
    Drug Deliv; 2020 Dec; 27(1):200-215. PubMed ID: 31983258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entrapment of Papain in Chitosan-Polyethylene Glycol Hybrid Nanohydrogels: Presenting a Model for Protein Delivery Systems.
    Jafari N; Najavand S; Pazhang M; Matin AA
    Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38555332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-genipin nanohydrogel as a vehicle for sustained delivery of alpha-1 antitrypsin.
    Ghasemi A; Mohtashami M; Sheijani SS; Aliakbari K
    Res Pharm Sci; 2015; 10(6):523-34. PubMed ID: 26779272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleic Acid Coated Gelatin Nanoparticles Impregnated Gel for Sustained Delivery of Zaltoprofen: Formulation and Textural Characterization.
    Pawar S; Pande V
    Adv Pharm Bull; 2015 Nov; 5(4):537-48. PubMed ID: 26819927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.
    Desai KG
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):107-58. PubMed ID: 27651100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M; Grabnar I; Ahlin Grabnar P
    Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
    Shahbazi MA; Hamidi M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.